Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

Modern Pathology, Published online: 07 September 2021; doi:10.1038/s41379-021-00911-wDeep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

Source: Modern Pathology - September 7, 2021 Category: Pathology Authors: Saman Farahmand Aileen I. Fernandez Fahad Shabbir Ahmed David L. Rimm Jeffrey H. Chuang Emily Reisenbichler Kourosh Zarringhalam Source Type: research